Cancer Research UK has collated some of the guidelines from official sources on the collection and processing of human specimens for clinical and translational research during and after the COVID-19 pandemic into a single document.
UCLH is part of the Oxford COVID-19 vaccine trial and expected to recruit 500 participants in June.
Staff at Cardiff's ECMC have been transferring their talents to help tackle the pandemic, engaging in the rapid set-up and recruitment to COVID-related studies.
Gary Doherty (Addenbrooke's Hospital) and colleagues have re-evaluated the processes of clinical research and published new guidlines for 'future-proofing' cancer clinical trials in Nature Cancer.
The UK Coronavirus Cancer Monitoring Project (UK CCMP) continues to make incredible strides in logging the majority of UK cases of COVID-19 in cancer patients.
The CRUK Centre for Drug Development (CDD) will sponsor and manage – at no extra cost to the charity - a nationally-prioritised clinical trial called SPIKE-1 to aid the efforts to find an effective treatment for COVID-19.
Southampton hosts a NIHR Biomedical Research Centre (BRC) with a focus on respiratory disease and our CRUK Clinical Trial Unit (CTU) there has also previously developed some non-cancer lung studies as it is also a NIHR CTU support funded CTU. Southampton CTU has been contributing its CRUK/NIHR staff expertise in study design, development and/or delivery of a number of COVID-19 trials
Technicians, admin staff, QA managers and various pieces of equipment in the Liverpool ECMC have been re-deployed to support the UK Clinical Characterisation protocol, part of ISARIC-4C.